These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16651404)

  • 1. Meeting report: exploiting the tumor microenvironment for therapeutics.
    Melillo G; Semenza GL
    Cancer Res; 2006 May; 66(9):4558-60. PubMed ID: 16651404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in understanding regulatory myeloid cells.
    Romano A; Vetro C; Adriani M
    Cancer Biol Ther; 2011 Jun; 11(11):923-6. PubMed ID: 21474999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
    Tyszka-Czochara M; Konieczny P; Majka M
    J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor hypoxia and malignant progression.
    Osinsky S; Zavelevich M; Vaupel P
    Exp Oncol; 2009 Jun; 31(2):80-6. PubMed ID: 19550396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies.
    Qiu GZ; Jin MZ; Dai JX; Sun W; Feng JH; Jin WL
    Trends Pharmacol Sci; 2017 Aug; 38(8):669-686. PubMed ID: 28602395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review.
    Thakkar S; Sharma D; Kalia K; Tekade RK
    Acta Biomater; 2020 Jan; 101():43-68. PubMed ID: 31518706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin as a therapeutic target for cancer.
    Bandopadhyay M; Bulbule A; Butti R; Chakraborty G; Ghorpade P; Ghosh P; Gorain M; Kale S; Kumar D; Kumar S; Totakura KV; Roy G; Sharma P; Shetti D; Soundararajan G; Thorat D; Tomar D; Nalukurthi R; Raja R; Mishra R; Yadav AS; Kundu GC
    Expert Opin Ther Targets; 2014 Aug; 18(8):883-95. PubMed ID: 24899149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-1 in cancer therapy: two decade long story of a transcription factor.
    Soni S; Padwad YS
    Acta Oncol; 2017 Apr; 56(4):503-515. PubMed ID: 28358664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia and cancer cell metabolism.
    Huang D; Li C; Zhang H
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):214-9. PubMed ID: 24389642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxystressed tumor microenvironment potentiates epithelial to mesenchymal transition and alters cellular bioenergetics towards cancer progression.
    Sridaran D; Ramamoorthi G; MahaboobKhan R; Kumpati P
    Tumour Biol; 2016 Oct; 37(10):13307-13322. PubMed ID: 27460079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting the cancer niche: Tumor-associated macrophages and hypoxia as promising synergistic targets for nano-based therapy.
    Silva VL; Al-Jamal WT
    J Control Release; 2017 May; 253():82-96. PubMed ID: 28285930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Oxygen Homeostasis for Tumor Biology and Treatment.
    Garvalov BK; Acker T
    Adv Exp Med Biol; 2016; 903():169-85. PubMed ID: 27343096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor 1 and cancer pathogenesis.
    Semenza GL
    IUBMB Life; 2008 Sep; 60(9):591-7. PubMed ID: 18506846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic exchanges within tumor microenvironment.
    Chiarugi P; Cirri P
    Cancer Lett; 2016 Sep; 380(1):272-80. PubMed ID: 26546872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first Tianjin, China forum on tumor microenvironment.
    Keller ET; Li LY
    Cancer Res; 2011 Jan; 71(2):310-3. PubMed ID: 21224351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mathematical modeling of cancer metabolism.
    Medina MÁ
    Crit Rev Oncol Hematol; 2018 Apr; 124():37-40. PubMed ID: 29548484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor and its microenvironment: a synergistic interplay.
    Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G
    Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between cancer cells and endothelial cells: implications for tumor progression and intervention.
    Choi H; Moon A
    Arch Pharm Res; 2018 Jul; 41(7):711-724. PubMed ID: 29961196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hypoxia in tumor angiogenesis-molecular and cellular angiogenic crosstalk.
    Acker T; Plate KH
    Cell Tissue Res; 2003 Oct; 314(1):145-55. PubMed ID: 12898211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.
    Rupaimoole R; Calin GA; Lopez-Berestein G; Sood AK
    Cancer Discov; 2016 Mar; 6(3):235-46. PubMed ID: 26865249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.